Tag: Exscientia
Exscientia Presents Three Posters Demonstrating the Potential of the Precision Medicine Platform in Drug Discovery at the 2022 American Association for Cancer Research Annual Meeting
Exscientia plc (Nasdaq: EXAI) today announced details of its presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting, to be held April 8-13, 2022 at the Ernest…
Exscientia and the University of Oxford launch “Xcellomics”, a program designed to accelerate fundamental academic research and put new biology at the service of new drug discovery
A free program accessible to any university researcher interested in submitting a proposal Exscientia (Nasdaq: EXAI) and the University of Oxford’s Target Discovery Institute (Oxford TDI) today announce the launch…
Sanofi joins forces with Exscientia for drugs designed using artificial intelligence
PARIS (Agefi-Dow Jones) – Pharmaceutical company Sanofi announced on Friday that it has entered into a research collaboration and licensing agreement with artificial intelligence-driven pharmaceutical technology company Exscientia. UK-based “Exscientia…